Evidence map›Paper›PMID 28730336›Full record

ReviewJournal of molecular neuroscience : MN2017

Serologic Markers of Autism Spectrum Disorder.

T V Khramova, Anna L Kaysheva, Y D Ivanov, T O Pleshakova, I Y Iourov, S G Vorsanova, Y B Yurov, A A Schetkin, A I Archakov

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of molecular neuroscience : MN, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Recent Progress on Relevant microRNAs in Autism Spectrum Disorders.International journal of molecular sciences · 2020
    Review
  6. High Serum Levels of Serum 100 Beta Protein, Neuron-specific Enolase, Tau, Active Caspase-3, M30 and M65 in Children with Autism Spectrum Disorders.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2020
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

T V KhramovaUdmurt State University, Universitetskaya st 1, Izhevsk, Russia.
Anna L KayshevaV.N.Orekhovich Research Institute of Biomedical Chemistry, 10, Pogodinskaya st, Moscow, Russia, 119121. kaysheva1@gmail.com.ORCID http://orcid.org/0000-0003-4472-2016
Y D IvanovV.N.Orekhovich Research Institute of Biomedical Chemistry, 10, Pogodinskaya st, Moscow, Russia, 119121.
T O PleshakovaV.N.Orekhovich Research Institute of Biomedical Chemistry, 10, Pogodinskaya st, Moscow, Russia, 119121.
I Y IourovMental Health Research Centre, Kashirskoe shosse, 34, Moscow, Russia.
S G VorsanovaSeparated Structural Unit "Clinical Research Institute of Pediatrics at Pirogov Russian National Research Medical University Named After Y.E Veltishev", Ministry of Health of Russian Federation, Taldomskaya 2, Moscow, Russia.
Y B YurovMental Health Research Centre, Kashirskoe shosse, 34, Moscow, Russia.
A A SchetkinCenter for Medical Preventive Action, Navaginskaya st 9, Sochi, Russia.
A I ArchakovV.N.Orekhovich Research Institute of Biomedical Chemistry, 10, Pogodinskaya st, Moscow, Russia, 119121.
Institute of Biomedical Chemistry · RUMental Health Research Center of Russian Academy of Medical Sciences · RUNational Research Center for Preventive Medicine · RUPirogov Russian National Research Medical University · RUUdmurt State University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

According to WHO data, about 67 million people worldwide are affected by autism, and this number grows by 14% annually. Among the possible causes of autism are genetic modifications, organic lesions of the central nervous system, metabolic disorders, influence of viral and bacterial infections, chemical influence to the mother's body during pregnancy, etc. The conducted research shows that research papers published until today do not name any potential protein markers that meet the requirements of the basic parameters for evaluating the efficiency of disease diagnostics, in particular high sensitivity, specificity, and accuracy. Conducting proteomic research on a big scale in order to detect serologic markers of protein nature associated with development of autism spectrum disorders seems to be highly relevant.

Indexed as

Autism Spectrum DisorderAutoantibodiesBiomarkersCytokinesHumansPeptidesSerotoninAutoantibodiesBiomarkersCytokinesPeptidesSerotoninAutism spectrum disordersMass spectrometryProtein detectionProtein markers

Identifiers

PMID28730336
OpenAlexW2738191704

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.